Conflict of interest: Dr. Lars S⊘ndergaard is a proctor for CoreValve, Medtronics.
Valvular and Structural Heart Diseases
Infective endocarditis following transcatheter aortic valve replacement—: Diagnostic and management challenges
Article first published online: 4 MAY 2012
Copyright © 2012 Wiley Periodicals, Inc.
Catheterization and Cardiovascular Interventions
Volume 81, Issue 4, pages 623–627, March 2013
How to Cite
Loh, P. H., Bundgaard, H. and S⊘ndergaard, L. (2013), Infective endocarditis following transcatheter aortic valve replacement—: Diagnostic and management challenges. Cathet. Cardiovasc. Intervent., 81: 623–627. doi: 10.1002/ccd.24368
- Issue published online: 22 FEB 2013
- Article first published online: 4 MAY 2012
- Accepted manuscript online: 16 MAR 2012 10:43AM EST
- Manuscript Accepted: 12 FEB 2012
- Manuscript Revised: 26 DEC 2011
- Manuscript Received: 13 SEP 2011
- valvular heart disease;
- complications adult cath/intervention;
- paravalvular leaks
Transcatheter aortic valve replacement (TAVR) can improve the symptoms and prognosis of patients with severe aortic stenosis who, due to a high expected operative risk, would not have otherwise been treated surgically. If these patients develop prosthetic valve endocarditis, their presentations may be atypical causing a delay in the diagnosis and treatment. The management is also complicated by their comorbidities, and surgical treatment may not be feasible leading to a significant morbidity and mortality. We describe a case of an 85-year-old man with TAVI prosthetic valve endocarditis successfully treated medically, discuss the challenges in the diagnosis and management of such patients, and review available literature on the incidence and outcome of the condition. © 2012 Wiley Periodicals, Inc.